The U.S. FDA has approved Novo Nordisk’s (NYSE: NVO) Ozempic for reducing the risk of kidney failure and disease progression,
11 months ago
Novo Nordisk’s (NYSE: NVO) blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare
12 months ago
COPENHAGEN – Danish businesses are concerned about a possible trade conflict with the United States over Greenland, a major lobby
U.S. retail investor fund flows into Novo Nordisk (NYSE: NVO) surged 32-fold on Friday, as the Danish drugmaker’s weaker-than-expected obesity
1 year ago
COPENHAGEN – The Danish crown weakened on Friday after disappointing results from a late-stage trial of a new weight-loss drug
LONDON/COPENHAGEN – On Friday, Novo Nordisk (NYSE: NVO) revealed disappointing results in a late-stage trial for its experimental next-generation obesity
LONDON/COPENHAGEN – On Friday, Novo Nordisk (NYSE: NVO) shareholders sought to find out why such a high number of patients
SHANGHAI – As Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) expand sales of their popular diabetes and weight-loss
STOCKHOLM/LONDON – Novo Nordisk (NYSE: NVO), the Danish drugmaker, will invest 8.5 billion crowns ($1.20 billion) in a new facility
LONDON – Britons paying privately for obesity drugs are increasingly choosing Eli Lilly’s (NYSE: LLY) Mounjaro over Novo Nordisk’s (NYSE:
On Wednesday, Novavax (NASDAQ: NVAX), the U.S.-based vaccine maker, said it would sell its manufacturing facility in the Czech Republic
COPENHAGEN – Shares of weight-loss drug makers Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) rose on Tuesday after
